$10.24
+0.0150 (+0.147%)
At Close: Jun 03, 2026
The Best Stocks To Buy - 'Is It Over?' Edition
08:24pm, Friday, 20'th Mar 2020
Encouraging signs emerge, but stock-picking is key. Top large-cap, mid-cap, and small-cap sectors and stocks now. Plan for ongoing volatility, and watch for eme
Citigroup Inc. Grows Stake in ChemoCentryx Inc (NASDAQ:CCXI)
11:06am, Friday, 20'th Mar 2020
Citigroup Inc. lifted its holdings in shares of ChemoCentryx Inc (NASDAQ:CCXI) by 446.6% during the fourth quarter, according to the company in its most recent Form 13F filing with the SEC. The fund o
7 “Perfect 10” Healthcare Stocks to Buy Now
04:15pm, Wednesday, 18'th Mar 2020
Wall Street pros recommend making an investment decision based on multiple factors rather than just a single metric like fundamentals.
Critical Review: Phoenix Tree (NASDAQ:IMAB) and ChemoCentryx (NASDAQ:CCXI)
05:36am, Tuesday, 17'th Mar 2020
Phoenix Tree (NASDAQ:IMAB) and ChemoCentryx (NASDAQ:CCXI) are both medical companies, but which is the better business? We will contrast the two businesses based on the strength of their analyst recom
Why ChemoCentryx (CCXI) Stock Might be a Great Pick
01:47pm, Monday, 16'th Mar 2020
ChemoCentryx (CCXI) has seen solid earnings estimate revision activity over the past month, and belongs to a strong industry as well
Why ChemoCentryx (CCXI) Stock Might be a Great Pick
01:47pm, Monday, 16'th Mar 2020
ChemoCentryx (CCXI) has seen solid earnings estimate revision activity over the past month, and belongs to a strong industry as well
ChemoCentryx Inc (NASDAQ:CCXI) to Post Q1 2020 Earnings of ($0.31) Per Share, SVB Leerink Forecasts
05:16am, Monday, 16'th Mar 2020
ChemoCentryx Inc (NASDAQ:CCXI) – Analysts at SVB Leerink increased their Q1 2020 earnings per share estimates for ChemoCentryx in a research note issued on Wednesday, March 11th. SVB Leerink analyst
Charles Schwab Investment Management Inc. Grows Stock Holdings in ChemoCentryx Inc (NASDAQ:CCXI)
10:08am, Sunday, 15'th Mar 2020
Charles Schwab Investment Management Inc. boosted its position in ChemoCentryx Inc (NASDAQ:CCXI) by 3.7% in the 4th quarter, according to its most recent filing with the SEC. The firm owned 100,310 sh
SVB Leerink Reaffirms Outperform Rating for ChemoCentryx (NASDAQ:CCXI)
06:30am, Sunday, 15'th Mar 2020
SVB Leerink reiterated their outperform rating on shares of ChemoCentryx (NASDAQ:CCXI) in a research report sent to investors on Wednesday, Zacks.com reports. Several other brokerages also recently is
ChemoCentryx Inc (NASDAQ:CCXI) Forecasted to Post Q1 2020 Earnings of ($0.30) Per Share
05:32am, Saturday, 14'th Mar 2020
ChemoCentryx Inc (NASDAQ:CCXI) – Investment analysts at Piper Sandler issued their Q1 2020 earnings per share (EPS) estimates for shares of ChemoCentryx in a report issued on Tuesday, March 10th. Pi
Edited Transcript of GALNA.S earnings conference call or presentation 12-Mar-20 1:00pm GMT
11:23pm, Thursday, 12'th Mar 2020
Full Year 2019 Vifor Pharma AG Earnings Call
Breathe - Here Are The Best Stocks To Buy Now
06:50pm, Thursday, 12'th Mar 2020
Markets are scary, but chasing returns is a losing strategy. Stocks are oversold, but margin remains a sharp-edged blade. Here are the top sectors and stocks no
ChemoCentryx, Inc. Just Reported Full-Year Earnings And Analysts Are Lifting Their Estimates
11:00am, Thursday, 12'th Mar 2020
There's been a notable change in appetite for ChemoCentryx, Inc. (NASDAQ:CCXI) shares in the week since its full-year...
Earnings Update: ChemoCentryx, Inc. Just Reported And Analysts Are Boosting Their Estimates
10:52am, Thursday, 12'th Mar 2020
There's been a notable change in appetite for ChemoCentryx, Inc. (NASDAQ:CCXI) shares in the week since its full-year...
J.P. Morgan Sticks to Its Buy Rating for ChemoCentryx (CCXI)
06:07pm, Wednesday, 11'th Mar 2020
In a report released today, Anupam Rama from J.P. Morgan maintained a Buy rating on ChemoCentryx (CCXI), with a price target of $61.00. The company's
Sign In
Buy CCXI